Literature DB >> 21108595

Diagnosis and assessment of Crohn's disease: the present and the future.

Gianluca Benevento1, Claudio Avellini, Giovanni Terrosu, Marco Geraci, Ilva Lodolo, Dario Sorrentino.   

Abstract

Diagnosis of Crohn's disease (CD) is often challenging and requires the utmost precision and perseverance in defining location, extent, severity and type of disease (inflammatory vs stricturing/penetrating), as well as in excluding septic complications and extraintestinal manifestations. Endoscopy and histology remain, as of today, the best tests for initial diagnosis of CD. Increasingly important roles are played by imaging techniques (small bowel MRI, computed tomographic enterography and intestinal ultrasound) and noninvasive markers of disease such as fecal calprotectin and specific autoantibodies. Here, we will review the main tools presently available to make the initial diagnosis of intestinal and perianal CD, to evaluate the response to treatment and to diagnose disease recurrence after surgery. Finally, we will discuss some of the future diagnostic challenges in CD.

Entities:  

Mesh:

Year:  2010        PMID: 21108595     DOI: 10.1586/egh.10.70

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  9 in total

1.  Fecal Lactoferrin and Other Stool Markers during Normal Pregnancy and in Inflammatory Bowel Diseases: A Prospective Study and Review of the Literature.

Authors:  James M Gray; Kristin Knight; Vu Q Nguyen; Marrieth G Rubio; Lauren Irby; James H Boone; Dario Sorrentino
Journal:  Inflamm Intest Dis       Date:  2020-07-01

2.  Fecal Lactoferrin Predicts Primary Nonresponse to Biologic Agents in Inflammatory Bowel Disease.

Authors:  Dario Sorrentino; Vu Q Nguyen; Kim Love
Journal:  Dig Dis       Date:  2021-02-25       Impact factor: 2.404

3.  Transmembrane TNF-α Density, but not Soluble TNF-α Level, is Associated with Primary Response to Infliximab in Inflammatory Bowel Disease.

Authors:  Azade Amini Kadijani; Hamid Asadzadeh Aghdaei; Dario Sorrentino; Alireza Mirzaei; Shabnam Shahrokh; Hedieh Balaii; Vu Q Nguyen; Jessica L Mays; Mohammad Reza Zali
Journal:  Clin Transl Gastroenterol       Date:  2017-09-14       Impact factor: 4.488

Review 4.  Capturing the Biologic Onset of Inflammatory Bowel Diseases: Impact on Translational and Clinical Science.

Authors:  Dario Sorrentino; Vu Q Nguyen; Maithili V Chitnavis
Journal:  Cells       Date:  2019-06-06       Impact factor: 6.600

5.  Fecal lactoferrin accurately reflects mucosal inflammation in inflammatory bowel disease.

Authors:  Marrieth G Rubio; Kofi Amo-Mensah; James M Gray; Vu Q Nguyen; Sam Nakat; Douglas Grider; Kim Love; James H Boone; Dario Sorrentino
Journal:  World J Gastrointest Pathophysiol       Date:  2019-12-31

6.  Gastrointestinal dysbiosis and Escherichia coli pathobionts in inflammatory bowel diseases.

Authors:  Andreas Munk Petersen
Journal:  APMIS       Date:  2022-08       Impact factor: 3.428

7.  Immunomodulation and Generation of Tolerogenic Dendritic Cells by Probiotic Bacteria in Patients with Inflammatory Bowel Disease.

Authors:  Shaghayegh Baradaran Ghavami; Abbas Yadegar; Hamid Asadzadeh Aghdaei; Dario Sorrentino; Maryam Farmani; Adil Shamim Mir; Masoumeh Azimirad; Hedieh Balaii; Shabnam Shahrokh; Mohammad Reza Zali
Journal:  Int J Mol Sci       Date:  2020-08-29       Impact factor: 5.923

8.  Timely Monitoring of Inflammation by Fecal Lactoferrin Rapidly Predicts Therapeutic Response in Inflammatory Bowel Disease.

Authors:  Dario Sorrentino; James M Gray
Journal:  Inflamm Bowel Dis       Date:  2021-07-27       Impact factor: 5.325

Review 9.  Wireless Capsule Endoscopy for Diagnosis and Management of Post-Operative Recurrence of Crohn's Disease.

Authors:  Adil Mir; Vu Q Nguyen; Youssef Soliman; Dario Sorrentino
Journal:  Life (Basel)       Date:  2021-06-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.